DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG [SIN15521P]

Active Ingredient and Strength

VENLAFAXINE HYDROCHLORIDE 169.71 MG EQV VENLAFAXINE - 150 MG

Dosage Form

CAPSULE, DELAYED RELEASE

Manufacturer and Country

PHARMATHEN S.A. - GREECE
PHARMATHEN INTERNATIONAL S.A. - GREECE

Registration Number

SIN15521P

Licence Holder

SEA PHARMA CONSULTANCY PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

N06AX16